AAAAAA

   
Results: 1-20 |
Results: 20
A PROSPECTIVE RANDOMIZED TRIAL COMPARING CYCLOSPORINE-A AND PREDNISONE (CSA PSE) VERSUS CYCLOSPORINE-A, METHOTREXATE AND PREDNISONE (CSA/MTX/PSE) FOR THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE - EFFECT ON CHRONIC GRAFT-VERSUS-HOST DISEASE AND LONG-TERM SURVIVAL/
Authors: ROSS M FORMAN SJ WONG RM SCHMIDT GM NILAND JC AMYLON MD DAGIS AC LONG GD NADEMANEE AP NEGRIN RS ODONNELL MR PARKER PM SMITH EP SYNDER DS STEIN AS BLUME KG CHAO NJ
Citation: M. Ross et al., A PROSPECTIVE RANDOMIZED TRIAL COMPARING CYCLOSPORINE-A AND PREDNISONE (CSA PSE) VERSUS CYCLOSPORINE-A, METHOTREXATE AND PREDNISONE (CSA/MTX/PSE) FOR THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE - EFFECT ON CHRONIC GRAFT-VERSUS-HOST DISEASE AND LONG-TERM SURVIVAL/, Blood, 90(10), 1997, pp. 2624-2624
IN-VIVO PURGING WITH HIGH-DOSE CYTARABINE FOLLOWED BY HIGH-DOSE CHEMORADIOTHERAPY AND REINFUSION OF UNPURGED BONE-MARROW FOR ADULT ACUTE MYELOGENOUS LEUKEMIA IN FIRST COMPLETE REMISSION
Authors: STEIN AS ODONNELL MR CHAI A SCHMIDT GM NADEMANEE A PARKER PM SMITH EP SNYDER DS MOLINA A STEPAN DE SPIELBERGER R SOMLO G MARGOLIN KA VORA N LIPSETT J LEE J NILAND J FORMAN SJ
Citation: As. Stein et al., IN-VIVO PURGING WITH HIGH-DOSE CYTARABINE FOLLOWED BY HIGH-DOSE CHEMORADIOTHERAPY AND REINFUSION OF UNPURGED BONE-MARROW FOR ADULT ACUTE MYELOGENOUS LEUKEMIA IN FIRST COMPLETE REMISSION, Journal of clinical oncology, 14(8), 1996, pp. 2206-2216
POLYMYOSITIS AS A MANIFESTATION OF CHRONIC GRAFT-VERSUS-HOST DISEASE
Authors: PARKER P CHAO NJ BENEZRA J SLATKIN N OPENSHAW H NILAND JC LINKER CA GREFFE BS KASHYAP A MOLINA A NADEMANEE A ODONNELL MR PLANAS I SHEIBANI K SMITH EP SNYDER DS SPIELBERGER R STEIN AS STEPAN DE BLUME KG FORMAN SJ
Citation: P. Parker et al., POLYMYOSITIS AS A MANIFESTATION OF CHRONIC GRAFT-VERSUS-HOST DISEASE, Medicine, 75(5), 1996, pp. 279-285
ACUTE POLYNEUROPATHY AFTER HIGH-DOSE CYTOSINE-ARABINOSIDE IN PATIENTSWITH LEUKEMIA
Authors: OPENSHAW H SLATKIN NE STEIN AS HINTON DR FORMAN SJ
Citation: H. Openshaw et al., ACUTE POLYNEUROPATHY AFTER HIGH-DOSE CYTOSINE-ARABINOSIDE IN PATIENTSWITH LEUKEMIA, Cancer, 78(9), 1996, pp. 1899-1905
HIGH-DOSE CHEMO RADIOTHERAPY (HDT) AND G-CSF PRIMED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) IN FOLLICULAR LOW-GRADE (FLGL) AND TRANSFORMED (TL) LYMPHOMA/
Authors: MOLINA A NADEMANEE A ODONNELL MR SNYDER DS STEIN AS PARKER PM SMITH EP LEE J PLANAS I KASHYAP A SPIELBERGER RT MARGOLIN K SOMLO G KAPOOR N CHOW W VORA N SNIECINSKI I NILAND J FORMAN SJ
Citation: A. Molina et al., HIGH-DOSE CHEMO RADIOTHERAPY (HDT) AND G-CSF PRIMED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) IN FOLLICULAR LOW-GRADE (FLGL) AND TRANSFORMED (TL) LYMPHOMA/, Blood, 88(10), 1996, pp. 472-472
DO CYTOGENETICS PREDICT OUTCOME OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE MYELOGENOUS LEUKEMIA (AML) IN 1ST REMISSION (CR)
Authors: STEIN AS ODONNELL MR SLOVAK M LEE J KASHYAP A MOLINA A NADEMANEE A PARKER P PLANAS I SNYDER DS SPIELBERGER R SOMLO G MARGOLIN K NILAND J FORMAN SJ
Citation: As. Stein et al., DO CYTOGENETICS PREDICT OUTCOME OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE MYELOGENOUS LEUKEMIA (AML) IN 1ST REMISSION (CR), Blood, 88(10), 1996, pp. 1928-1928
ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IN PATIENTS (PTS) WITH INCURABLE LOW-GRADE LYMPHOPROLIFERATIVE DISORDERS (LGLPD)
Authors: MOLINA A PARKER P STEIN AS SPIELBERGER R NADEMANEE A SNYDER DS ODONNELL MR SMITH EP MARGOLIN K DAGIS A PLANAS I KASHYAP A SOMLO G KAPOOR N VORA N NILAND J FORMAN SJ
Citation: A. Molina et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IN PATIENTS (PTS) WITH INCURABLE LOW-GRADE LYMPHOPROLIFERATIVE DISORDERS (LGLPD), Blood, 88(10), 1996, pp. 2465-2465
BUSULFAN CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASIA/
Authors: ODONNELL MR LONG GD PARKER PM NILAND J NADEMANEE A AMYLON M CHAO N NEGRIN RS SCHMIDT GM SLOVAK ML SMITH EP SNYDER DS STEIN AS TRAWEEK T BLUME KG FORMAN SJ
Citation: Mr. Odonnell et al., BUSULFAN CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASIA/, Journal of clinical oncology, 13(12), 1995, pp. 2973-2979
THE ASSOCIATION OF HIGH-DOSE ARA-C AND DEMYELINATING POLYNEUROPATHY
Authors: OPENSHAW H SLATKIN NE HINTON DR ZAIAS B STEIN AS
Citation: H. Openshaw et al., THE ASSOCIATION OF HIGH-DOSE ARA-C AND DEMYELINATING POLYNEUROPATHY, Annals of neurology, 38(2), 1995, pp. 342-342
THALIDOMIDE AS SALVAGE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE
Authors: PARKER PM CHAO N NADEMANEE A ODONNELL MR SCHMIDT GM SNYDER DS STEIN AS SMITH EP MOLINA A STEPAN DE KASHYAP A PLANAS I SPIELBERGER R SOMLO G MARGOLIN K ZWINGENBERGER K WILSMAN K NEGRIN RS LONG GD NILAND JC BLUME KG FORMAN SJ
Citation: Pm. Parker et al., THALIDOMIDE AS SALVAGE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE, Blood, 86(9), 1995, pp. 3604-3609
IDARUBICIN (IDA) AND HIGH-DOSE CYTOSINE-ARABINOSIDE (HD ARA-C) FOR INDUCTION THERAPY FOR AML AND AML ARISING FROM MYELODYSPLASIA (MDS AML)/
Authors: STEIN AS ODONNELL MR NADEMANEE A PARKER P LEE J MOLINA A KASHYAP A SPIELBERGER R SMITH E PLANAS I SNYDER D SOMLO G MARGOLIN K NILAND J FORMAN SJ
Citation: As. Stein et al., IDARUBICIN (IDA) AND HIGH-DOSE CYTOSINE-ARABINOSIDE (HD ARA-C) FOR INDUCTION THERAPY FOR AML AND AML ARISING FROM MYELODYSPLASIA (MDS AML)/, Blood, 86(10), 1995, pp. 2046-2046
HIGH-DOSE CHEMOTHERAPY WITH OR WITHOUT TOTAL-BODY IRRADIATION FOLLOWED BY AUTOLOGOUS BONE-MARROW AND OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RELAPSED AND REFRACTORY HODGKINS-DISEASE - RESULTS IN 85 PATIENTS WITH ANALYSIS OF PROGNOSTIC FACTORS/
Authors: NADEMANEE A ODONNELL MR SNYDER DS SCHMIDT GM PARKER PM STEIN AS SMITH EP MOLINA A STEPAN DE SOMLO G MARGOLIN KA SNIECINSKI I DAGIS AC NILAND J PEZNER R FORMAN SJ
Citation: A. Nademanee et al., HIGH-DOSE CHEMOTHERAPY WITH OR WITHOUT TOTAL-BODY IRRADIATION FOLLOWED BY AUTOLOGOUS BONE-MARROW AND OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RELAPSED AND REFRACTORY HODGKINS-DISEASE - RESULTS IN 85 PATIENTS WITH ANALYSIS OF PROGNOSTIC FACTORS/, Blood, 85(5), 1995, pp. 1381-1390
PREDICTION OF SYSTEMIC FUNGAL INFECTION IN ALLOGENEIC MARROW RECIPIENTS - IMPACT OF AMPHOTERICIN PROPHYLAXIS IN HIGH-RISK PATIENTS
Authors: ODONNELL MR SCHMIDT GM TEGTMEIER BR FAUCETT C FAHEY JL ITO J NADEMANEE A NILAND J PARKER P SMITH EP SNYDER DS STEIN AS BLUME KG FORMAN SJ
Citation: Mr. Odonnell et al., PREDICTION OF SYSTEMIC FUNGAL INFECTION IN ALLOGENEIC MARROW RECIPIENTS - IMPACT OF AMPHOTERICIN PROPHYLAXIS IN HIGH-RISK PATIENTS, Journal of clinical oncology, 12(4), 1994, pp. 827-834
HIGH-DOSE THERAPY FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA USING UNPRIMED AND GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS
Authors: NADEMANEE A SNIECINSKI I SCHMIDT GM DAGIS AC ODONNELL MR SNYDER DS PARKER PM STEIN AS SMITH EP MOLINA A STEPAN DE SOMLO G MARGOLIN KA WOO D NILAND JC FORMAN SJ
Citation: A. Nademanee et al., HIGH-DOSE THERAPY FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA USING UNPRIMED AND GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS, Journal of clinical oncology, 12(10), 1994, pp. 2176-2186
FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE ETOPOSIDE AS A PREPARATORY REGIMEN FOR BONE-MARROW TRANSPLANTATION FOR 94 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE
Authors: SNYDER DS NEGRIN RS ODONNELL MR CHAO NJ AMYLON MD LONG GD NADEMANEE AP STEIN AS PARKER PM SMITH EP SOMLO G MARGOLIN K MOLINA A STEPAN DE LIPSETT JA HOPPE RT SLOVAK ML NILAND JC DAGIS AC WONG RM FORMAN SJ BLUME KG
Citation: Ds. Snyder et al., FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE ETOPOSIDE AS A PREPARATORY REGIMEN FOR BONE-MARROW TRANSPLANTATION FOR 94 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE, Blood, 84(5), 1994, pp. 1672-1679
HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR REFRACTORY HODGKINS-DISEASE (HD) - RESULTS AND ANALYSIS OF PROGNOSTIC FACTORS
Authors: NADERMANEE A ODONNELL M SNYDER DS SCHMIDT GM PARKER PM STEIN AS SMITH EP MOLINA A STEPAN DE WONG KK SOMLO G MARGOLIN KA SNIECINSKI I DAGIS AC NILAND J PEZNER R FORMAN SJ
Citation: A. Nadermanee et al., HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR REFRACTORY HODGKINS-DISEASE (HD) - RESULTS AND ANALYSIS OF PROGNOSTIC FACTORS, Blood, 84(10), 1994, pp. 10000206-10000206
CYCLOSPORINE, METHOTREXATE, AND PREDNISONE COMPARED WITH CYCLOSPORINEAND PREDNISONE FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE
Authors: CHAO NJ SCHMIDT GM NILAND JC AMYLON MD DAGIS AC LONG GD NADEMANEE AP NEGRIN RS ODONNELL MR PARKER PM SMITH EP SNYDER DS STEIN AS WONG RM BLUME KG FORMAN SJ
Citation: Nj. Chao et al., CYCLOSPORINE, METHOTREXATE, AND PREDNISONE COMPARED WITH CYCLOSPORINEAND PREDNISONE FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE, The New England journal of medicine, 329(17), 1993, pp. 1225-1230
FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE ETOPOSIDE AS A PREPARATORY REGIMEN FOR BONE-MARROW TRANSPLANTATION FOR 99 PATIENTS WITH ACUTE-LEUKEMIA IN 1ST COMPLETE REMISSION
Authors: SNYDER DS CHAO NJ AMYLON MD TAGUCHI J LONG GD NEGRIN RS NADEMANEE AP ODONNELL MR SCHMIDT GM STEIN AS PARKER PM SMITH EP STEPAN DE MOLINA A LIPSETT JA HOPPE RT NILAND JC DAGIS AC WONG RM FORMAN SJ BLUME KG
Citation: Ds. Snyder et al., FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE ETOPOSIDE AS A PREPARATORY REGIMEN FOR BONE-MARROW TRANSPLANTATION FOR 99 PATIENTS WITH ACUTE-LEUKEMIA IN 1ST COMPLETE REMISSION, Blood, 82(9), 1993, pp. 2920-2928
HIGH-DOSE THERAPY (HDT) AND AUTOLOGOUS G-CSF-PRIMED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) FOR FOLLICULAR LOW-GRADE LYMPHOMA (FLGL)
Authors: MOLINA A NADEMANEE A ODONNELL MR SNYDER DS PARKER PM STEIN AS SMITH EP STEPAN DE WONG KK LEE JY MARGOLIN KA SOMLO G RASCHKO J SNIECINSKI I NILAND J FORMAN SJ
Citation: A. Molina et al., HIGH-DOSE THERAPY (HDT) AND AUTOLOGOUS G-CSF-PRIMED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) FOR FOLLICULAR LOW-GRADE LYMPHOMA (FLGL), Blood, 82(10), 1993, pp. 10000145-10000145
ALLOGENEIC (ALLO) VERSUS AUTOLOGOUS (AUTO) BONE-MARROW TRANSPLANTATION (BMT) FOR AML IN 1ST COMPLETE REMISSION (CR)
Authors: STEIN AS SNYDER D NADEMANEE A ODONNELL MR TOMITA A PARKER PM SMITH E SOMLO G MARGOLIN K MOLINA A WONG KK STEPAN D LIPSETT J NILAND J SCHMIDT GM FORMAN SJ
Citation: As. Stein et al., ALLOGENEIC (ALLO) VERSUS AUTOLOGOUS (AUTO) BONE-MARROW TRANSPLANTATION (BMT) FOR AML IN 1ST COMPLETE REMISSION (CR), Blood, 82(10), 1993, pp. 10000168-10000168
Risultati: 1-20 |